Observational registry of chronic kidney diseases in China

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the occurrence, development, treatment, prognosis, and related risk factors of chronic kidney disease (CKD) within the mainland Chinese population. It utilizes a multi-center approach to gather real-world data, allowing for a comprehensive analysis of CKD's impact on health and the economy. The study will include a diverse group of participants, including diagnosed CKD patients, individuals with risk factors, and healthy volunteers, to ensure a robust dataset for analysis. By establishing a standardized data network, the study seeks to enhance data collection and integration across multiple centers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with CKD as defined in the KDIGO Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease 2012 Edition;
* Non-CKD patients with hypertension, diabetes, hyperlipidemia, hyperuricemia, eGFR (CKD-EPI formula) of 60-89 ml/min/1.73m\^2 and other risk factors for CKD;
* Healthy population.
* Signed the informed consent voluntarily.

Exclusion Criteria:

。Patients identified to be unsuitable for enrollment by the study physician.

Where it's running

• Guangdong Provincial Peoples Hospital
  Guangzhou, Guangdong, China Recruiting
• The Second People's Hospital of Nanhai District in Foshan City
  Foshan, Guangdong, China Not yet recruiting
• The First Affiliated Hospital of Sun Yat-sen University
  Guangzhou, Guangdong, China Not yet recruiting
• Wuhua County People's Hospital
  Meizhou, Guangdong, China Not yet recruiting
• Fogang County People's Hospital
  Qingyuan, Guangdong, China Not yet recruiting
• People's Hospital of Yingde
  Qingyuan, Guangdong, China Not yet recruiting

Study contacts

• Principal investigator: Feng Wen, MD — Guangdong Provincial People's Hospital
• Study coordinator: Xueqing Yu, MD
• Email: yuxueqing@gdph.org.cn
• Phone: +86-20-83827812

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Observational look at how Kremezin works in adults with advanced chronic kidney disease

  This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.

  Recruiting HK inno.N Corporation · Seoul · NCT07930169

• Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China

  This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.

  Recruiting Phase 4 Novo Nordisk A/S · Fuyang, Anhui and 25 other locations · NCT07900438

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• Arterial stiffness in children and young people with CKD and hypertension

  This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.

  Recruiting King's College London · London, Greater London · NCT07768865

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.